Details for 2013786186
Up to date per 02.04.2026
Actions
Details for 2013786186
Granted/Registered
European Patent
19.08.2015 A
27.09.2017 B1
12.10.2012
US
201261712924 P
12.10.2012
US
201261712928 P
15.03.2013
US
201361794997 P
15.03.2013
US
201361794922 P
15.03.2013
US
201361794954 P
A61K 47/68 20170101AFI20170306BHEP
Owner
ADC Therapeutics SARoute de la Corniche 3B 1066 EpalingesCH
Medimmune LimitedMilstein Building Granta Park Cambridge, Cambridgeshire CB21 6GHGB
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
VAN BERKEL, Patricius Hendrikus CornelisADC Therapeutics Sàrl Rue Saint-Pierre 2 C/O Michael Forer 1003 LausanneCH
HOWARD, Philip WilsonSpirogen Limited The QMB Innovation Centre 42 New Road London Greater London E1 2AXGB
Information about Fees